Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Safety of 100IR, 300IR, 500IR Sublingual House Dust Mite (HDM) Tablets in Allergic Rhinitis Environment Exposure Chamber Model
This study is ongoing, but not recruiting participants.
Study NCT01527188   Information provided by Stallergenes

First Received on February 1, 2012.   Last Updated on February 3, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
House Dust Mites Allergic Rhinitis
Additional conditions recognized in this trial
Rhinitis
More general conditions related to this trial
Nose Diseases
Otorhinolaryngologic Diseases
Respiratory Tract Diseases
Respiratory Tract Infections
Interventions listed in this trial
100IR
300IR
500IR
Placebo
Sponsors listed in this trial
Stallergenes


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services